Velneperit
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet
Shionogi · Phase 2 · Completed · Enrollment 724
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| S-2367 Placebo | n/r | n/r | n/r | n/r | n/r |
| S-2367 800 mg | n/r | n/r | n/r | n/r | n/r |
| S-2367 1600 mg | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.